Inhibrx Biosciences, Inc. (INBX) Dividend Yield, History & Forecast

Inhibrx Biosciences, Inc. (INBX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ Global Market. The most recent ex-dividend date was May 30, 2024, with payment scheduled for June 20, 2024. market capitalization is approximately $928M.

Loading quote...

Frequently Asked Questions about Inhibrx Biosciences, Inc. (INBX)

When does Inhibrx Biosciences, Inc. pay its next dividend?
The most recent ex-dividend date was May 30, 2024. The next scheduled dividend payment date is June 20, 2024.
Is Inhibrx Biosciences, Inc. a Dividend Aristocrat?
Dividend Aristocrat status requires an S&P 500 listing and 25 or more consecutive years of dividend increases. See our curated Dividend Aristocrats list for the full roster.
What sector is Inhibrx Biosciences, Inc. in?
Inhibrx Biosciences, Inc. (INBX) operates in the Healthcare sector, specifically the Biotechnology industry.